3rd Quarter - Report

THE PERSONAL CARE PRODUCTS COUNCIL for PERSONAL CARE PRODUCTS COUNCIL

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Canadian non-tariff trade barriers- Executive Branch actions re this issue.

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR)

Budget/Appropriations BUD

FY-09 Agriculture Appropriations S.3289/No Health Bill- FDA Appropriations related to increased funding for the Office of Cosmetics and Colors within CFSAN

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: SENATE; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 3289 (110th)

Consumer Issues/Safety/Products CSP

Food safety legislation, import safety, FDA user fee- HR 3610, Food and Drug Import Safety Act of 2007; proposed legislation re these issues. Proposed legislation by Rep John Dingell (discussion draft of the Food & Drug Globalization Act of 2008) related to the regulation of cosmetics. Nanotechnology research - HR 5940, National Nanotechnology Initiative Amendments Act of 2008; proposed legislation re this issue.

LobbyistCovered position, as disclosed
PAMELA G BAILEY —
JOHN A HURSON —
MICHAEL F THOMPSON —

Contacted: Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Bills named: H.R. 3610 (110th), H.R. 5940 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.